Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...

Background and objectives Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer.

Eligible patients with previously untreated, metastatic squamous non–small-cell lung cancer (NSCLC) were randomly assigned 1:1 to pembrolizumab 200 mg or placebo plus carboplatin and ...

Rates of community referral for chest X-ray and lung cancer stage (TNM seventh edition) at presentation were collected from 2008 to 2015. Linear trends were assessed by χ 2 test for trend in ...

Abstract: Detection of lung cancer at early stages is critical ... based automated decision support system for lung nodule detection and classification. The mRFCN is used as an image classifier ...

Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT ... but focused on the accuracy of AI-based software for the ...

SANTA MONICA, Calif. — A California man battling lung cancer is unable to get treatment he planned for after being denied by his health insurance company Cigna Healthcare. Daron Wells ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas. The first patient was dosed in the SKYBRIDGE ...

Susan Riffle had a lesion on her lung that AI determined was likely cancer. The disease was caught at stage 1, and she avoided chemotherapy and radiation Wendy Grossman Kantor is an award-winning ...